DNA Analysis of Blood and Tissue from Patients with Lung Cancer

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT00471978
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Accepted

Study Details

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.

Key Dates

Start date
Sep 30, 2005
Status verified
Nov 2024
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Primary Outcome Measure

Metabolic polymorphisms [ Time Frame: 10 years ]

Locations (2)

FacilityCityStateZIPSite coordinators
Harvard School of Public HealthBostonMassachusetts02115
David C. Christiani, MD
617-726-9274
Massachusetts General HospitalBostonMassachusetts02114
Clinical Trials Office - Massachusetts General Hospital
877-726-5130

Find similar trials in Boston, MA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Harvard School of Public Health· Boston, MAMassachusetts General Hospital· Boston, MA

Related Studies